Litigation Details for CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2017)
CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2017)
| Docket | 2:17-md-02789 | Date Filed | 2017-08-04 |
| Court | District Court, D. New Jersey | Date Terminated | 2024-02-14 |
| Cause | 28:1332 Diversity-Product Liability | Assigned To | Claire Claudia Cecchi |
| Jury Demand | Plaintiff | Referred To | Leda Dunn Wettre |
| Patents | 7,045,620; 7,612,199; 7,902,206; 8,158,644; 8,158,781; 8,193,196; 8,722,684 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .
Details for CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-08-04 | 210 | Opinion | number of prior art patents, including U.S. Patent Number 7,045,620 (“’620 Patent”), Number 7,612,199…following four patents: the ’355 Patent, the ’915 Patent, the ’415 Patent, and the ’257 Patent (together …absorption. (’355 Patent at 4:6–8; ’915 Patent at 1:24–31; ’415 Patent at 1:26–33; ’257 Patent at 1:26–33;… θ. (’355 Patent at 1:55–2:45; ’915 Patent at 1:58–67; ’415 Patent at 1:60–67; ’257 Patent at 1:60–67… The ’915 Patent, ’415 Patent, and ’257 Patent The remaining three patents in this case—the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
